exenatide twice daily

DRUG4 trials

Sponsors

AstraZeneca

Conditions

Diabetes Mellitus, Type 2Type 2 DiabetesType 2 Diabetes Mellitus

Phase 3

A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)

CompletedNCT00877890

AstraZenecaType 2 Diabetes Mellitus

Start: 2009-03-31End: 2010-01-31Updated: 2015-04-07

A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects

CompletedNCT00917267

AstraZenecaType 2 Diabetes Mellitus

Start: 2009-07-31End: 2011-04-30Updated: 2015-04-09

Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes

CompletedNCT01652716

AstraZenecaDiabetes Mellitus, Type 2

Start: 2013-01-31End: 2014-08-31Updated: 2018-07-03

Unknown Phase

Clinical Outcomes of Exenatide Versus Basal Insulin

CompletedNCT02987348

AstraZenecaType 2 Diabetes

Start: 2015-06-30End: 2015-06-30Updated: 2017-03-29

Related Papers

Further improvement in glycemic control after switching from exenatide two times per day to exenatide once-weekly autoinjected suspension in patients with type 2 diabetes: 52-week results from the DURATION-NEO-1 study

BMJ Open Diabetes Research & Care2020-10-014 citations

Onset of Glycemic and Weight Outcomes in Patients Initiating Exenatide Once Weekly: The Relationship of Exenatide Exposure with Efficacy over the First 24 Weeks of Treatment.

2016-05-053 citations

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01

Efficacy, safety, and tolerability of exenatide once weekly in patients with type 2 diabetes mellitus: an integrated analysis of the DURATION trials.

2013-05-0151 citations

Safety of exenatide once weekly for 52 weeks in Japanese patients with type 2 diabetes mellitus.

2012-10-2210 citations

Development and validation of the self-management profile for type 2 diabetes (SMP-T2D).

2012-10-0516 citations

Efficacy and safety of exenatide once-weekly vs exenatide twice-daily in Asian patients with type 2 diabetes mellitus.

2012-09-1463 citations